Kamada (KMDA) director reports stock option holdings in Form 3 filing
Filing Impact
Filing Sentiment
Form Type
3
Rhea-AI Filing Summary
Kamada Ltd. director Assaf Itshayek filed a Form 3 reporting existing holdings of stock options for Ordinary Shares. The filing lists four option positions, each covering 4,000 underlying Ordinary Shares at an exercise price of $6.26 per share, expiring on March 7, 2030, with different future exercise dates from September 7, 2024 through September 7, 2027. The options are exercisable using a net-exercise method, and the U.S. dollar exercise prices reflect a convenience translation from New Israeli Shekels based on the Bank of Israel exchange rate as of March 13, 2026.
Positive
- None.
Negative
- None.
Insider Trade Summary
4 transactions reported
Mixed
4 txns
Insider
ITSHAYEK ASSAF
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Options to purchase Ordinary Shares | -- | -- | -- |
| holding | Options to purchase Ordinary Shares | -- | -- | -- |
| holding | Options to purchase Ordinary Shares | -- | -- | -- |
| holding | Options to purchase Ordinary Shares | -- | -- | -- |
Holdings After Transaction:
Options to purchase Ordinary Shares — 4,000 shares (Direct)
Footnotes (1)
- These options to purchase ordinary shares are exercisable using a net-exercise method All exercise prices presented in U.S. dollars represent a convenience translation from NIS based on the representative exchange rate of the Bank of Israel as of March 13, 2026.
FAQ
What does Kamada (KMDA) disclose in Assaf Itshayek’s Form 3?
The Form 3 shows director Assaf Itshayek reporting existing holdings of stock options for Kamada’s Ordinary Shares. It details four option positions, each tied to 4,000 underlying shares, establishing his initial derivative ownership as a reporting insider.
What are the exercise terms of Assaf Itshayek’s Kamada (KMDA) stock options?
All reported options have an exercise price of $6.26 per Ordinary Share and expire on March 7, 2030. The filing lists different exercise dates between September 7, 2024 and September 7, 2027, indicating a staged exercisability schedule.
How are Kamada (KMDA) option exercise prices presented in Assaf Itshayek’s Form 3?
The exercise prices are shown in U.S. dollars, translated from New Israeli Shekels. A footnote explains they use the representative exchange rate of the Bank of Israel as of March 13, 2026 for convenience of presentation.
What exercise method applies to Assaf Itshayek’s Kamada (KMDA) stock options?
A footnote states these options to purchase ordinary shares are exercisable using a net-exercise method. Under this approach, the holder receives a net number of shares after accounting for the option exercise value instead of paying cash for all shares.